Table 2.
Effect of l-NAME on systemic and pulmonary arterial pressure and on cardiac output
| Systemic Arterial Pressure, mmHg |
Pulmonary Arterial Pressure, mmHg |
Normalized Cardiac Output, ml·min−1·100 gms−1 |
||||||
|---|---|---|---|---|---|---|---|---|
| n | Control | l-NAME | Control | l-NAME | Control | l-NAME | Increase in Pulmonary Vascular Resistance, mmHg·ml−1·min−1 | |
| 1 mg/kg iv | 6 | 109 ± 7 | 133 ± 8* | 19 ± 1 | 25 ± 1* | 36 ± 3 | 33 ± 4 | 0.11 ± 0.05* |
| 5 mg/kg iv | 15 | 97 ± 4 | 123 ± 4* | 18 ± 3 | 24 ± 1* | 32 ± 1 | 23 ± 1 | 0.15 ± 0.03* |
| 10 mg/kg iv | 11 | 101 ± 4 | 134 ± 6* | 17 ± 1 | 28 ± 1* | 32 ± 2 | 24 ± 2 | 0.23 ± 0.02* |
| 50 mg/kg iv | 20 | 88 ± 4 | 128 ± 6* | 16 ± 1 | 27 ± 1* | 33 ± 1 | 21 ± 1 | 0.25 ± 0.02* |
| 100 mg/kg iv | 24 | 96 ± 2 | 141 ± 3* | 18 ± 1 | 28 ± 1* | 27 ± 1 | 16 ± 1 | 0.32 ± 0.02* |
Values are means ± SE.
P < 0.05 compared with control. l-NAME, nitro-l-arginine methyl ester.